You are here

  • Home
  • Archive
  • Volume 28, Issue e1
  • Economic evaluation of subcutaneous versus intravenous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy: a real-life study

Article metrics

Article menu
Download PDFPDF
Original research
Economic evaluation of subcutaneous versus intravenous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy: a real-life study

 

Online download statistics by month:

Online download statistics by month: October 2020 to September 2024

AbstractFullPdf
Oct 202029811
Nov 20207121921
Dec 20206655
Jan 202119812
Feb 202111832
Mar 20217901
Apr 20218310
May 20214113
Jun 2021601
Jul 2021811
Aug 2021723
Sep 2021813
Oct 202114422
Nov 20213410
Dec 202117942
Jan 202210641
Feb 202214602
Mar 202211512
Apr 202210613
May 202212722
Jun 202216320
Jul 202210823
Aug 20228001
Sep 202217223
Oct 202211420
Nov 20229921
Dec 20223200
Jan 20233201
Feb 20239601
Mar 20238421
Apr 20236300
May 20236514
Jun 202310110
Jul 20239411
Aug 20232710
Sep 20231620
Oct 20233700
Nov 20233210
Dec 202313100
Jan 202410002
Feb 20246501
Mar 20244421
Apr 20249511
May 20247300
Jun 202410000
Jul 20248310
Aug 20248610
Sep 20245100
Total48247478